Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

MDM2 Promotes Ubiquitin-Independent Degradation of HoxA9: Implications for MLL-Fusion Protein Mediated Transformation.

Huiwu Zhao, PhD, Shenghao Jin, Ph.D., Alan M. Gewirtz, M.D.

Blood (2006) 108 (11): 1418.

https://doi.org/10.1182/blood.V108.11.1418.1418

Published: 2006

Journal Articles

The Proto-Oncogene Myb Augments Transcription of the Neuropeptide Neuromedin U in Human Myeloid Leukemias.

Susan E. Shetzline, PhD, Joseph Conlon, B.S., Cezary Swider, Ph.D., Lindsay Thalheim, B.S., Alan M. Gewirtz, M.D.

Blood (2006) 108 (11): 2254.

https://doi.org/10.1182/blood.V108.11.2254.2254

Published: 2006

Journal Articles

Effects of SB559457, a Novel Small Molecule Thrombopoietin Receptor (TpoR) Agonist, on Human Hematopoietic Cell Growth and Differentiation.

Anna Kalota, MS, Kistin Brennan, Connie L. Erickson-Miller, Gwenn Danet, PhD, Martin Carroll, M.D., Alan M. Gewirtz, M.D.

Blood (2004) 104 (11): 2913.

https://doi.org/10.1182/blood.V104.11.2913.2913

Published: 2004

Journal Articles

Countering Low-Linear Energy Transfer (LET) and High-LET Radiation Exposure with Pro-Methyl Hoechst (PMH) and EUK-134 (Mg-Salen Complex): Radioprotection of Normal Human CD34 + Cells in a Simulated Deep Space Environment.

Gurudutta U. Gangenahalli, Ph.D., John M. Millholland, Ph.D., Anna Kalota, Ph.D., Paula Bennett, Ph.D., Betsy M. Sutherland, Ph.D., Alan M. Gewirtz, M.D.

Blood (2004) 104 (11): 4158.

https://doi.org/10.1182/blood.V104.11.4158.4158

Published: 2004

Journal Articles

Acute Myeloid Leukemia Cells Contain Constitutively Activated STAT3 and Require STAT3 for Survival.

Tae Kon Kim, M.D., Martin Carroll, M.D., Alan M. Gewirtz, M.D.

Blood (2004) 104 (11): 3368.

https://doi.org/10.1182/blood.V104.11.3368.3368

Published: 2004

Journal Articles

Intra-S-Phase Regulator cdc7 Is a Gene Target of the c-Myb Proto-Oncogene in Human Leukemias.

Susan E. Shetzline, Ph.D., June Hsu, B.A., Lindsay Thalheim, B.A., John K. Choi, M.D. Ph.D., Alan M. Gewirtz, M.D.

Blood (2004) 104 (11): 2039.

https://doi.org/10.1182/blood.V104.11.2039.2039

Published: 2004

NARROW

MDM2 Promotes Ubiquitin-Independent Degradation of HoxA9: Implications for MLL-Fusion Protein Mediated Transformation.

The Proto-Oncogene Myb Augments Transcription of the Neuropeptide Neuromedin U in Human Myeloid Leukemias.

Effects of SB559457, a Novel Small Molecule Thrombopoietin Receptor (TpoR) Agonist, on Human Hematopoietic Cell Growth and Differentiation.

Countering Low-Linear Energy Transfer (LET) and High-LET Radiation Exposure with Pro-Methyl Hoechst (PMH) and EUK-134 (Mg-Salen Complex): Radioprotection of Normal Human CD34 + Cells in a Simulated Deep Space Environment.

Acute Myeloid Leukemia Cells Contain Constitutively Activated STAT3 and Require STAT3 for Survival.

Intra-S-Phase Regulator cdc7 Is a Gene Target of the c-Myb Proto-Oncogene in Human Leukemias.

Email alerts

ASH Publications

American Society of Hematology

MDM2 Promotes Ubiquitin-Independent Degradation of HoxA9: Implications for MLL-Fusion Protein Mediated Transformation.

The Proto-Oncogene Myb Augments Transcription of the Neuropeptide Neuromedin U in Human Myeloid Leukemias.

Effects of SB559457, a Novel Small Molecule Thrombopoietin Receptor (TpoR) Agonist, on Human Hematopoietic Cell Growth and Differentiation.

Countering Low-Linear Energy Transfer (LET) and High-LET Radiation Exposure with Pro-Methyl Hoechst (PMH) and EUK-134 (Mg-Salen Complex): Radioprotection of Normal Human CD34 + Cells in a Simulated Deep Space Environment.

Acute Myeloid Leukemia Cells Contain Constitutively Activated STAT3 and Require STAT3 for Survival.

Intra-S-Phase Regulator cdc7 Is a Gene Target of the c-Myb Proto-Oncogene in Human Leukemias.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only